Chris Elliott Fund

Entries for the ‘News’ Category

THANK YOU VICKI PENE for BEING PART OF THE CURE!

“After graduating with a Marketing degree from San Diego State in 1987, I somehow ended up in the hotel industry as a catering manager, planning meetings and weddings. Feeling unsettled in my job by the time 1997 came around  I was looking for a new direction. After much aptitude testing, a career counselor suggested I [...]

Introducing The Elliott Foundation — working to EndBrainCancer through national patient support services!

        We are so excited to share this with you. The Chris Elliott Fund has now become The Elliott Foundation! We are starting 2012 with an expanded vision, a new name, and a new look.   All of the rebranding and what we call our “capacity build out” project is designed to [...]

Maria Barrett’s Testimony for The Elliott Foundation/Chris Elliott Fund’s Work, Mission & Vision – The Importance of Knowing About Genetic Testing of One’s LIVE Brain Tumor Tissue Before You Need to Know It!

Hi Dellann, I’ve been listening to your radio talk show from January 4th. I wanted to let you know that their write up has the wrong date listed for your tour of the Ivy Brain Center and Cyber Knife you mentioned. It says January 19th vs January 16th. We actually have an appt with Dr. [...]

There is much to celebrate! Here are our 2011 CEF HIGHLIGHTS:

• Over 60,000 brain cancer patients, family members, and caregivers received vital information and support about advanced brain tumor treatment and access to advanced treatment centers known for their excellence. • In April, the FDA approved NovoTTF device as a new treatment option for brain cancer.  CEF President Dellann Elliott testified before the FDA as [...]

Letter from Senator Patty Murray

Dear Ms. Elliott: Thank you for contacting me with your support for funding of the National Institutes of Health (NIH).  It is good to hear from you. As a member of the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, I have been very supportive of funding for biomedical research [...]